ALASTIN Skincare, Inc. Announces Appointment of James P. Hartman as Chief Commercial Officer

CARLSBAD, CA — May 9, 2018 — ALASTIN Skincare, Inc. ( —a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products with proprietary TriHex Technology® that enhance, protect, and maintain healthy skin for a lifetime—has announced the appointment of James P. Hartman to the position of Chief Commercial Officer effective May 14, 2018.

Mr. Hartman holds a proven track record of successful business leadership and development of leading brands in the medical aesthetics arena. He most recently served as Vice President & General Manager at Solta Medical, a division of Valeant Pharmaceuticals. Prior to Solta, he was at Merz Aesthetics where he was the Vice President & U.S. Head of Aesthetics & OTC. Mr. Hartman also served as Vice President, Global Marketing and Business Development at Obagi Medical, building that company into the leading physician-dispensed skin care brand during his tenure.

"We are extremely pleased to have Jim join ALASTIN as a key member of the executive team to lead our commercialization activities as we continue the rapid growth of our current products and build our product pipeline", said Diane S. Goostree, President and CEO of ALASTIN Skincare. "Jim's extensive operating background in the medical aesthetics space, including experience with energy-based rejuvenating devices, is a natural fit for us as we develop and launch new products and expand our sales force."

"I am thrilled to have the opportunity to lead Alastin’s commercial organization as the company leverages its market-disrupting TriHex Technology to expand the physician-dispensed aesthetics industry," stated Mr. Hartman. "Minimally invasive rejuvenating procedures are a fast-growing segment of the aesthetics industry, and differentiated, efficacious products such as ALASTIN’s Procedure Enhancement line provide optimal outcomes and reduced downtime for patients while building physicians’ practices and the aesthetic market overall."


About ALASTIN Skincare®, Inc.

ALASTIN Skincare® is dedicated to developing innovative, clinically-tested skin care products that correct, protect and maintain healthy skin for a lifetime. Our unparalleled Procedure Enhancement and Restore & Renew products are formulated with our TriHex Technology®, a patented combination of key peptides and other synergistic ingredients using the latest technology and are clinically tested to demonstrate safety and their ability to help reawaken the skin’s youthful regenerating processes.


Behrman Communications
Amanda Reinstein, Account Director
(212) 986-7000

Join the A-List

Stay in the glow with the latest beauty and skincare trends, products, and procedures.


Other pages you might like

ALASTIN Skincare® Launches INhance Post-Injection Serum with TriHex Technology® Clinically Tested Formula Accelerates Recovery and Minimizes Post-Injection Downtime

CARLSBAD, CA — January 27, 2020— ALASTIN Skincare®, Inc., a specialty aesthetics company dedicated to developing and marketing innovative, clinica ...

ALASTIN Skincare® Named Fastest Growing Brand in the Professional Skincare Market for the Third Consecutive Year

CARLSBAD, CA — January 15, 2020—ALASTIN Skincare®, Inc., a specialty aesthetics company dedicated to developing and marketing innovative, clinical ...

ALASTIN Skincare® Announces Issuance of Third U.S. Patent for their Revolutionary TransFORM Body Treatment with TriHex Technology®

CARLSBAD, Calif., Dec. 18, 2019 -- ALASTIN Skincare®, Inc. - a specialty aesthetics company dedicated to developing and marketing innovative, cli ...